No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
BOLD Boundless Bio
- 9.670
- -0.290-2.91%
Close May 17 16:00 ET
215.05MMarket Cap-4349P/E (TTM)
10.010High9.430Low92.48KVolume9.750Open9.960Pre Close896.20KTurnover1.48%Turnover RatioLossP/E (Static)22.24MShares15.24052wk High-1.69P/B60.44MFloat Cap8.51052wk Low--Dividend TTM6.25MShs Float15.240Historical High--Div YieldTTM5.82%Amplitude8.510Historical Low9.690Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Boundless Bio Inc. Shifts Corporate Updates to IR Website
Boundless Bio, Inc. Q1 Loss Climbs
Boundless Bio | 10-Q: Quarterly report
Express News | Boundless Bio Inc: First Patient Dosed in Phase 1/2 Starmap Clinical Trial of Bbi-825 in Patients With Tumors With Resistance Gene Amplifications
Express News | Boundless: Bbi-355 Phase 1/2 Potentiate Clinical Trial Ongoing;Initiated Therapy Combinations for Tumors With Egfr/Fgfr Oncogene Amplifications
Boundless Bio 1Q Loss/Shr $12.27 >BOLD
Boundless Bio 1Q Loss/Shr $12.27 >BOLD
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
